文献速递神经肿瘤

内镜下经鼻入路治疗原发性视神经鞘脑膜瘤的系统综述

Endoscopic Endonasal Approach for Primary Optic Nerve Sheath Meningioma: A Systematic Review.
PubMed 文献 · World Neurosurg · 2026-01-20

本系统综述遵循PRISMA指南,纳入5项研究共13例影像学确诊的原发性视神经鞘脑膜瘤(ONSM)患者,评估内镜下经鼻入路(EEA)减压视神经的视力结局与并发症。结果显示5例视力改善、7例稳定、1例恶化,无术中或术后并发症报告,提示EEA对特定病例安全有效。

要点

  • EEA可用于特定原发性ONSM的视神经减压,13例中5例视力改善、7例稳定。
  • 纳入研究中无术中或术后并发症报告。
  • 1例术前已属WHO“视力差”者随访24个月视力恶化至盲。

核心结论

  • EEA对特定原发性ONSM病例是安全有效的微创视神经减压方式,有助于保留受威胁的视力。

研究设计与样本

  • 遵循PRISMA指南的系统综述,筛选1065篇文章,最终纳入5项研究共13例患者。
  • 纳入标准为年龄>16岁、影像学确诊原发性ONSM且局限于视神经管,排除继发性ONSM或存在颅内延伸者。

主要发现

  • 术后13例中5例视力改善(VA LogMAR评分下降≥0.2),7例稳定(LogMAR变化<0.2)。
  • 1例在2年随访时视力恶化(VA LogMAR增加>0.2),该例术前已符合WHO“视力差”标准(≥0.5 LogMAR)。
  • 该例术后前6个月视力稳定,但12和24个月LogMAR分别为1.38和1.78,恶化至WHO盲标准(LogMAR>1.3)。
  • 纳入研究中未报告术中或术后并发症。

临床怎么用

  • 对于影像学确诊、局限于视神经管的原发性ONSM,EEA可作为保留视力的微创减压选项。
  • 术前视力已差(WHO标准≥0.5 LogMAR)者术后仍可能长期恶化,需个体化评估与随访。

局限性

  • 证据仅基于5项研究共13例患者,样本量小。
  • 原文未报告长期疗效、最佳手术时机及与放疗整合的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary optic nerve sheath meningioma (ONSM) is a rare but clinically significant benign tumor that can cause irreversible loss of vision. Active management strategies in primary ONSM are controversial, and current treatment favors radiotherapy, despite its associated risks. Endoscopic endonasal approach (EEA) surgery offers a minimally invasive alternative to decompress the optic nerve and restore visual function. This systematic review evaluates the effectiveness and safety of EEA for decompression of the optic nerve, focusing on visual outcomes and complications. METHODS: A systematic review was performed following PRISMA guidelines to identify studies reporting operative management using EEA in patients above 16 years with radiographically confirmed primary ONSM that demonstrate optic canal confinement, excluding studies evaluating secondary ONSM or tumors with any evidence of intracranial extension. Post-operative outcome data were collected including visual acuity (VA), visual fields and complications. RESULTS: A total of 1065 articles were screened, with 13 patients included across 5 studies. VA improved post-operatively in 5 out of 13 patients (≥ 0.2 decrease in VA LogMAR score) and VA scores were stable in 7 out of 13 patients, post-operatively (where change in LogMAR score <0.2). One patient had worsened vision at 2-year follow-up (>0.2 increase in VA LogMAR score). Of note, this patient had established criteria for "poor vision" pre-operatively, as defined by World Health Organization (WHO) (≥ 0.5 LogMAR) and although vision was stable during the first 6 months of follow-up, VA deteriorated to WHO criteria for blindness (LogMAR > 1.3) with scores of 1.38 and 1.78 LogMAR at 12 and 24 months, respectively. No intraoperative or postoperative complications were reported in the included studies. CONCLUSIONS: These results suggest that EEA offers a safe and effective minimally invasive approach in preserving threatened vision for selected primary ONSM cases. Further research is required to determine optimal timing, long-term efficacy, and integration with radiotherapy.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sivanathan S, Al-Rabadi J, Alexander KG, et al. Endoscopic Endonasal Approach for Primary Optic Nerve Sheath Meningioma: A Systematic Review. World Neurosurg. 2026. PMID: 41570978. doi:10.1016/j.wneu.2026.124817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。